12006512

Source:http://linkedlifedata.com/resource/pubmed/id/12006512

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0012550, umls-concept:C0023467, umls-concept:C0079460, umls-concept:C0162768, umls-concept:C0205269, umls-concept:C0205314, umls-concept:C0679622, umls-concept:C0920321
pubmed:issue	5
pubmed:dateCreated	2002-5-13
pubmed:abstractText	Patients with relapsed or refractory acute myeloid leukemia have a poor prognosis. We tested the safety and efficacy of a diphtheria fusion protein [diphtheria toxin (DT)388 granulocyte-macrophage colony-stimulating factor (GMCSF)] directed against the GMCSF receptor that is strongly expressed by leukemic blasts.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/1R01CA76178, http://linkedlifedata.com/resource/pubmed/grant/1R21CA90550, http://linkedlifedata.com/resource/pubmed/grant/M01RR07122
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9502500
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Alanine Transaminase, http://linkedlifedata.com/resource/pubmed/chemical/Aspartate Aminotransferases, http://linkedlifedata.com/resource/pubmed/chemical/Cytokines, http://linkedlifedata.com/resource/pubmed/chemical/Diphtheria Toxin, http://linkedlifedata.com/resource/pubmed/chemical/Granulocyte-Macrophage..., http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Thymidine
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	1078-0432
pubmed:author	pubmed-author:CaseL DouglasLD, pubmed-author:FrankelArthur EAE, pubmed-author:HallPhilip DPD, pubmed-author:KreitmanRobert JRJ, pubmed-author:PowellBayard LBL
pubmed:issnType	Print
pubmed:volume	8
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1004-13
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:12006512-Acute Disease, pubmed-meshheading:12006512-Adolescent, pubmed-meshheading:12006512-Adult, pubmed-meshheading:12006512-Aged, pubmed-meshheading:12006512-Aged, 80 and over, pubmed-meshheading:12006512-Alanine Transaminase, pubmed-meshheading:12006512-Aspartate Aminotransferases, pubmed-meshheading:12006512-Bone Marrow Cells, pubmed-meshheading:12006512-Child, pubmed-meshheading:12006512-Cytokines, pubmed-meshheading:12006512-Diphtheria Toxin, pubmed-meshheading:12006512-Female, pubmed-meshheading:12006512-Granulocyte-Macrophage Colony-Stimulating Factor, pubmed-meshheading:12006512-Humans, pubmed-meshheading:12006512-Hypocalcemia, pubmed-meshheading:12006512-Leukemia, Myeloid, pubmed-meshheading:12006512-Liver Failure, pubmed-meshheading:12006512-Male, pubmed-meshheading:12006512-Middle Aged, pubmed-meshheading:12006512-Neoplasm Recurrence, Local, pubmed-meshheading:12006512-Partial Thromboplastin Time, pubmed-meshheading:12006512-Recombinant Fusion Proteins, pubmed-meshheading:12006512-Renal Insufficiency, pubmed-meshheading:12006512-Thymidine, pubmed-meshheading:12006512-Treatment Outcome, pubmed-meshheading:12006512-Tumor Cells, Cultured
pubmed:year	2002
pubmed:articleTitle	Phase I trial of a novel diphtheria toxin/granulocyte macrophage colony-stimulating factor fusion protein (DT388GMCSF) for refractory or relapsed acute myeloid leukemia.
pubmed:affiliation	Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina 27157, USA. afrankel@wfubmc.edu
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't, Clinical Trial, Phase I